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In May 1999 we changed our approach to the man-
agement of endoleak on the basis of a review of our results
in 114 patients who underwent elective endovascular
abdominal aortic aneurysm repair over the preceding 3
years. Before that time, all patients with endoleak at 2
weeks underwent immediate angiographic localization
and further endovascular treatment. We now attempt to
categorize endoleaks on the basis of computed tomogra-
phy (CT) findings and treat type I endoleaks immediately.
Type II endoleaks are treated only if the aneurysm
enlarges. This report describes the findings that prompted
these changes.
METHODS
Patient selection. Patients were selected for inclusion
in this study on the basis of two sets of criteria as described
previously.4 Only patients considered “high risk” were eli-
gible. The designation “high-risk” was based on a variable
assortment of clinical and laboratory criteria. We did not
apply a rigorous system of preoperative testing and risk
quantification, having decided that no patient would be
considered too sick to undergo endovascular unless their
Persistent perfusion of the space between the stent-
graft and the aneurysm wall (endoleak) is the most com-
mon failure mode of endovascular repair.1-13 Endoleak is
sometimes associated with continuing aneurysm dilation10
or rupture,12-15 but not always.11 The uncertain signifi-
cance of endoleak, particularly type II or branch endoleak,
is reflected in the wide variety of approaches to its man-
agement. Some authors treat all types of endoleak
promptly4; others treat endoleak only if it is associated
with an increase in aneurysm diameter.3
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Purpose: We sought to assess the role of endovascular techniques in the management of perigraft flow (endoleak) after
endovascular repair of an abdominal aortic aneurysm.
Method: We performed endovascular repair of abdominal aortic aneurysm in 114 patients, using a variety of Gianturco
Z-stent–based prostheses. Results were evaluated with contrast-enhanced computed tomography (CT) at 3 days, 3
months, 6 months, 12 months, and every year after the operation. An endoleak that occurred 3 days after operation
led to repeat CT scanning at 2 weeks, followed by angiography and attempted endovascular treatment.
Results: Endoleak was seen on the first postoperative CT scan in 21 (18%) patients and was still present at 2 weeks in
14 (12%). On the basis of angiographic localization of the inflow, the endoleak was pure type I in 3 cases, pure type II
in 9, and mixed-pattern in 2. Of the 5 type I endoleaks, 3 were proximal and 2 were distal. All five resolved after
endovascular implantation of additional stent-grafts, stents, and embolization coils. Although inferior mesenteric
artery embolization was successful in 6 of 7 cases and lumbar embolization was successful in 4 of 7, only 1 of 11 pri-
mary type II endoleaks was shown to be resolved on CT scanning. There were no type III or type IV endoleaks
(through the stent-graft). Endoleak was associated with aneurysm dilation two cases. In both cases, the aneurysm
diameter stabilized after coil embolization of the inferior mesenteric artery. There were two secondary (delayed)
endoleaks; one type I and one type II. The secondary type I endoleak and the associated aneurysm rupture were treated
by use of an additional stent-graft. The secondary type II endoleak was not treated.
Conclusions: Type I endoleaks represent a persistent risk of aneurysm rupture and should be treated promptly by
endovascular means. Type II leaks are less dangerous and more difficult to treat, but coil embolization of feeding arter-
ies may be warranted when leakage is associated with aneurysm enlargement. (J Vasc Surg 2001;34:98-105.)
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life expectancy was less than 2 years. We assessed the fea-
sibility of endovascular aneurysm repair by use of CT scan-
ning and catheter angiography. Suitable patients were
enrolled in the study after full informed consent was
obtained in accordance with the requirements of our insti-
tutional committee on human research.
Stent-graft sizing. Preoperative measurements of
neck diameter and aneurysm diameter were based on CT
scanning. Measurements of neck length, aneurysm length,
common iliac artery length, external iliac artery diameter,
and neck and iliac angulation were based on angiography
by use of calibrated catheters. In most cases, measure-
ments of common iliac artery diameter were based on
angiography, which we found to be more precise than CT,
especially when the arteries were tortuous, heavily calci-
fied, and of variable caliber. However, iliac artery
aneurysm diameters were based on the findings of CT
scanning because mural thrombus precluded accurate
angiographic measurement.
Anticoagulation. Eight (7%) patients were given war-
farin (Coumadin) before undergoing endovascular aneurysm
repair. The Coumadin was discontinued 5 days before oper-
ation and resumed before discharge. Antiplatelet therapy (in
most cases aspirin) was continued. No anticoagulants or
antiplatelet agents were prescribed as part of this study.
Stent-graft insertion. These patients were treated
under two FDA investigational device exemptions: one
for a custom-made system of our own, and the other for
the Zenith system (Cook, Inc, Bloomington, Ind). All
repairs were performed in the operating room, and most
(74%) were performed with the patients under epidural
anesthesia. We used our custom-made system of aor-
tomonoiliac stent-graft implantation, together with
femorofemoral bypass and contralateral common iliac
artery occlusion, in 91 cases, and an aortoaortic version
of this custom-made system in 10 cases. Zenith bifur-
cated stent-grafts were implanted in 13 cases. System
design and operative technique have been described
elsewhere.4
Intraoperative angiograms were studied for signs of
endoleak. Type I endoleaks were treated with a variety of
adjunctive maneuvers, including balloon dilation and
reorientation of the proximal stent, additional stent
implantation, and additional stent-graft implantation.16
No patient left the operating room with angiographic
signs of type I endoleak. Intraoperative type II endoleaks
were ignored.
Routine CT-based follow-up. Routine follow-up
included contrast-enhanced CT scanning before dis-
charge, which was repeated at 3 months, 6 months, 12
months, and annually thereafter. When we began this
study, the follow-up evaluation was based on a standard
abdominal CT protocol. The resulting volumetric data set
was reconstructed and displayed as a series of 10-mm axial
slices. We found these studies to be insensitive, nonspe-
cific, and imprecise in the diagnosis and localization of
Fig 1. A, Contrast-enhanced CT scan shows area of high density (arrow), which might be read as endoleak. 
B, Corresponding noncontrast CT scan shows same area of high density (arrow), which cannot be result of ongoing
endoleak because no contrast was present in circulating blood at time of scan.
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endoleaks.17 During the course of the study, we made a
series of incremental changes in both the acquisition and
processing of CT data. Our current practice is as follows.
We acquire data in three phases: before contrast infusion,
shortly after contrast infusion, and 1 to 2 minutes after
contrast infusion. The noncontrast series is used to iden-
tify areas of high density (Fig 1) present before contrast
infusion, which otherwise might lead to false-positive
reporting of endoleaks.17 The delayed series is used to
detect type II leaks, which often fill with contrast-
enhanced blood long after contrast enhancement of the
aorta. The variation in delay between contrast injection
and scanning depends on transit time, as assessed by 
timing the appearance of a 20-mL test bolus of contrast
(320 mg/mL iohexol) at the proximal end the field of
interest. The test bolus is administered at approximately
4 mL/s. Serial density readings from the center of the
aorta at the level of the celiac artery are plotted to show
the interval between peak opacification and the start of
the contrast infusion. The contrast-enhanced phase of
the study is performed with the same delay between the
start of contrast infusion (at approximately 4 mL/s for
150 mL) and the start of data acquisition. Data are
acquired from proximal to distal starting at the celiac
artery level. The slice thickness is 3 mm, and the pitch is
1.5 to 2.0. Three-dimensional reconstruction (shaded
surface display and multiplanar reconstruction) aids in
the localization of leaks (Fig 2). Because many of our
patients were old, sick, and reluctant to travel long dis-
tances for routine studies, we often depended on outside
institutions for late follow-up, although not all adhered
to our CT protocol.
Angiograpic localization and treatment of
endoleak. Any patients with an endoleak on the first post-
operative CT scan were studied again at 2 weeks. Any with
a persistent leak at 2 weeks underwent catheter angiogra-
phy before repeat endovascular treatment.16-19
Angiographic localization of the inflow was the sole
basis for the endoleak categorization reported here. We
often found type I or mixed-type endoleaks difficult to
exclude on static CT-based images, especially early in the
study when the CT scans had poor longitudinal resolution
and no multiplanar reconstruction. Digital angiography
provided a more dynamic picture, in which contrast-
enhanced blood could be seen entering the aneurysm
through the site of leakage. We categorized an endoleak
on the basis of identification of the site of inflow, not out-
flow, for two reasons. First, there was usually only one site
of inflow, in contrast to the multiple sites of outflow.
Second, we usually directed treatment toward occlusion of
the inflow, while leaving the outflow to thrombose. The
presence of mixed-pattern leakage was established only
after an additional endovascular procedure had been per-
formed to eliminate the type I component.
Type I leaks were treated with embolization coils, addi-
tional stents, or stent-grafts. Two proximal type I endoleaks
required an additional stent-graft, and a third required an
additional stent to enhance the seal. In addition, one of
these patients was treated by occlusion of the lumbar arter-
ial outflow with embolization coils (Cook, Inc). Both distal
Fig 2. A, Contrast-enhanced axial CT scan show flow through lumbar artery (arrows) and resulting endoleak. 
B, Multiplanar reconstruction shows flow through aneurysm from one lumbar artery to another (arrows).
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type I endoleaks occurred around the iliac occluder. In one
case this pathway was blocked by transcatheter insertion of
large Tornado embolization coils (Cook, Inc), and in the
other by insertion of an additional occluder.
Type II leaks were treated in the angiography suite
with coils to occlude the terminal arteries of the collateral
pathway. We catheterized the feeding artery by following
the collateral circulation.16-19 In some cases the pathway
led from the superior mesenteric artery to the inferior
mesenteric artery (IMA) (Fig 3); in others from the inter-
nal iliac arteries to the lumbar arteries (Fig 4). The goal
was always to block the route of leakage as close to the
aneurysm as possible, thereby preserving perfusion of the
spine, colon, and pelvis. The internal iliac and superior
mesenteric arteries were catheterized by use of the coaxial
technique. The orifice was entered with a 5F angled
catheter, and the distal branches catheterized by use of a
Tracker-18 catheter (Target Theraputics, Inc, Mountain
View, Calif) over a 0.016-in Seeker guidewire (Target
Theraputics). Embolization of the feeding artery was per-
formed by use of 2- to 4-mm Tornado platinum coils
(Cook, Inc).
Data collection. Routine prospective data collection
included information on patient characteristics, preopera-
tive arterial anatomy, stent-graft type, postoperative inter-
ventions, postoperative changes in aneurysm diameter,
and the presence or absence of an endoleak. Before writ-
ing this report, we reviewed any equivocal findings, col-
lected any missing data, and called the patients and their
physicians to update clinical status. Two patients with
endoleaks died during follow-up. In both cases, the cause
of death was clear from the clinical course and neither
patient underwent an autopsy.
Statistical analysis. Cases were categorized according
to the phase of the study (first half vs second half), the type
of device (Zenith vs custom-made), the presence or
absence of the various types of endoleak, and the presence
or absence of various types of anatomic distortion. The
distribution of cases among these categories was assessed
by use of χ2 testing. Changes in aneurysm diameter were
assessed by use of a paired t test.
RESULTS
Between June 1996 and May 1999, we performed
elective endovascular repair of abdominal aortic
aneurysms in 114 patients. Endoleak was seen on the first
postoperative CT scan in 21 (18%) patients and was still
present at 2 weeks in 14 (12%). The patients with persis-
tent endoleak underwent angiographic localization of the
leak, which proved to be pure type I in 3, pure type II in
9, and a mixed-pattern leak in 2. Those that resolved
spontaneously underwent routine CT-based follow-up
Fig 3. A, Selective angiogram of superior mesenteric artery shows flow through marginal arcade into IMA (arrow) and
into aneurysm. B, Selective angiogram after embolization of the IMA trunk. IMA, Inferior mesenteric artery.
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study, and in these cases no attempt was made to localize
or categorize the endoleak.
There was no significant difference in ultimate
aneurysm size between patients with an endoleak at 2 weeks
(mean, 6.5 cm) and the group of all 114 treated patients
(mean, 6.3 cm). Mean follow-up in the persistent endoleak
group was 14.3 months. This includes two patients who had
less than 3 months of follow-up; one patient declined to
continue in the study, another died of a subdural hematoma
a month after implantation of a second stent-graft. A third
patient died 2 years after endovascular aneurysm repair. The
immediate cause was pneumonia complicating a stroke.
In the first half of the study, there were 2 cases of type
I endoleak, 1 case of type II endoleak, and 1 case of
mixed-type endoleak. The corresponding numbers for the
second half of the study were 1, 8, and 1, respectively. 
The only significant difference between the two halves of
the study was the number of type II endoleaks, which
occurred more frequently in the second half (P = .037).
There was no association between endoleak and the type
of device, the presence of a specific anatomic distortion, or
Coumadin anticoagulation. The anatomic distortions seen
most frequently among the 114 treated patients were as
follow: neck angulation > 45 degrees (37%), neck length 
< 15 mm (25%), iliac angulation > 90 degrees (20%), and
common iliac diameter > 25 mm (17%).
Aneurysm diameter increased by 3 and 9 mm in two
cases of type II endoleak during an unusually long delay
between stent-graft implantation and embolization of the
feeding arteries necessitated by other medical problems.
In both cases, there were signs of persistent endoleak on
some of the subsequent CT scans but no further increases
in aneurysm diameter. No other patients demonstrated
any significant (> 2 mm) increase in aneurysm diameter.
All five type I leaks (3 pure and 2 associated with type
II endoleak) resolved after endovascular treatment. In the
two cases of mixed endoleak, the type II endoleak was not
suspected until the type I endoleak had been obliterated.
One of these patients died a month later of a subdural
hematoma, whereas the other patient has had a 4-mm
decrease in aneurysm diameter, in spite of the persistence
of the type II endoleak. All three patients with pure type I
endoleak had a decrease in aneurysm diameter (mean,
12.3 mm) during follow-up.
There were nine cases of pure type II endoleak. In
addition to the two patients described above, whose leaks
seemed to appear and disappear after IMA and lumbar
embolization, only one other patient has shown signs of
endoleak resolution. This patient underwent IMA
embolization within a month of stent-graft implantation.
Although embolization was an effective means of IMA
occlusion in another three cases, an endoleak was seen on
a subsequent CT scan in all three because of the persistence
of lumbar collateral routes to the aneurysm. The IMA
appeared to be part of the endoleak circuit in seven cases,
including a case of mixed-type endoleak. Embolization
failed to achieve IMA occlusion in only one of seven
attempts. In this case, there were multiple connections
Fig 4. A, Selective angiogram of internal iliac artery shows ascending flow (arrows) into pair of lumbar arteries and from
there into aneurysm (arrow). B, Angiography after embolization of endoleak cavity, junction between lumbar arteries, and
one of ascending internal iliac artery branches (arrows).
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between the SMA and IMA branches, none of which was
large enough to admit a catheter.
In contrast, lumbar embolization failed in four of
seven attempts, usually because the ascending pathways,
from the internal iliac arteries to the lumbar arteries, were
small and multiple. Moreover, all three “angiographically
successful” lumbar artery embolizations can be assumed
to have been incomplete, because subsequent CT scan-
ning showed persistence of the endoleak through other
lumbar arteries.
All in all, there were eight cases with unresolved, or
intermittently resolved endoleaks, after 3 or more months
of follow-up. There was no statistically significant change in
aneurysm diameter in these cases. Mean aneurysm diameter
decreased only 0.5 mm (P = .66) during a mean follow-up
of 13.8 months. Even if one excludes the period before
embolization, the mean decrease in aneurysm diameter 
was only 2 mm (P = .12) during a mean follow-up of 
12 months. There were no signs of type III or type IV
endoleaks through defects in the fabric of the stent-graft.
In addition to the 14 cases of primary endoleak, there
were two cases of secondary (delayed) endoleak. In one
case, proximal stent migration caused secondary type I
endoleak and aneurysm rupture a year after stent-graft
implantation. This patient was treated by implantation of a
second stent-graft. At last follow-up, his aneurysm diame-
ter had decreased by more than 1 cm. A second patient
developed a secondary type II endoleak when he began to
receive Coumadin as prophylaxis against cardiogenic
embolism. Two patent lumbar arteries were seen adjacent
to the distal aneurysm at the level of the endoleak. On
review of the earlier CT scans, it appears these lumbar
arteries were patent all along. They were probably part of
a circuit, which involved some of the aneurysm sac, but not
enough to produce a positive CT finding of endoleak. This
aneurysm has not changed in diameter.
DISCUSSION
These results prompted several changes in our proto-
col (Table), most of which relate to the detection and
management of type II endoleaks. We still take a fairly
aggressive approach to type I endoleaks, treating all of
them early in the postoperative course, but we have started
to observe type II endoleaks.
We found that pure type I endoleaks were relatively
uncommon and easy to treat. We treated all primary type
I endoleaks within a month of the initial operation in the
belief that this type of leakage represents a high risk of
aneurysm dilation and rupture. We cannot assess this
belief on the basis of our own experience. However,
reported cases of aneurysm rupture after incomplete
endovascular aneurysm exclusion attest to the risk.13-15
Even when type I endoleaks resolve spontaneously, they
may reappear, and when they do the risk of rupture is even
higher.3,12 In our experience, the high risk of rupture was
demonstrated by the sole case of secondary type I
endoleak. This patient had no endoleak on any of the
scans performed in the first year after endovascular repair,
yet he returned 3 months later with a type I endoleak and
a ruptured aneurysm. Fortunately, the rupture was con-
tained, and we were able to eliminate the endoleak with an
additional stent-graft.
Our failure to demonstrate any anatomic risk factors
for type I endoleak probably reflects a lack of data. We had
only three leaks around the proximal end of the stent-graft
and two around the distal end. A high rate of type I leak-
age has been seen in cases with a short proximal implanta-
tion site.9 Although 25% of our patients had necks of 15
mm or less in length, we were careful to avoid cases in
which a short neck was associated with other unfavorable
features, such as angulation, thrombus lining, or conical
shape, and we ensured stable implantation by placing an
uncovered stent over the renal arteries whenever the neck
was shorter than 15 mm. Both cases of distal type I
endoleak had irregular, calcified common iliac arteries. Yet
there were many cases with these findings and no endoleak.
Type II endoleaks became more common as the study
progressed. We attribute this increasing incidence to more
sensitive diagnosis; type II endoleaks are easily missed
unless the scan is performed a minute or more after injec-
tion of intravenous contrast.11 The 16% rate seen in the
second half of this study probably represents the true inci-
Endoleak management
Study Finding Response
Intraoperative angiogram No endoleak 1-month CT
Type I endoleak Endovascular treatment
Type II endoleak 1-month CT
1-month CT No endoleak 6-month CT
Type I endoleak Endovascular treatment
Type II endoleak 3-month CT
3-month CT No endoleak 6-month CT
Type II endoleak (with < 3 mm AAA diameter increase) 6-month CT
Type II endoleak (with > 3 mm AAA diameter increase) Endovascular treatment
6-month CT No endoleak 12-month CT
Type II endoleak (with < 3 mm AAA diameter increase) 12-month CT
Type II endoleak (with > 3 mm AAA diameter increase) Endovascular treatment
AAA, Abdominal aortic aneurysm; CT, computed tomography.
dence. Other studies1-13 have reported rates of type II
endoleak ranging from 0% to 25%. We think these varying
rates reflect differences in diagnostic sensitivity. Perhaps
the underdiagnosis of type II endoleak is responsible for
the phenomenon of “endotension,” whereby aneurysms
remain pressurized and dilate, in spite of CT evidence of
complete exclusion.10,20
We found type II endoleaks difficult to eliminate
because the communicating arteries were often small and
multiple. Perhaps a more aggressive approach would have
yielded a higher success rate. When faced with multiple
ascending internal iliac branches to the lumbar arteries we
could have attempted to embolize them all, although this
maneuver has been known to cause paraplegia.11 When
faced with collateral vessels that would not admit a
catheter, we could have attempted to reach the lumbar
and inferior mesenteric arteries from the aneurysm side.
There are two possible routes into an aneurysm after
endovascular repair. One is around the end of a self-
expanding stent-graft and the other is translumbar. We
have obtained perigraft access to the aneurysm for
embolization of lumbar outflow from a type I endoleak in
two cases (one elective and one urgent), both of which
were successful. We have no experience with the translum-
bar route, which theoretically risks inducing aneurysm
rupture.
Perhaps it would be better to prevent type II
endoleaks by occluding potential collateral routes into the
aneurysm before or during stent-graft implantation.
However, selective catheterization of multiple small aortic
branches is sometimes difficult, and even dangerous, in
the presence of a thrombus-lined aneurysm. Moreover, in
the absence of a reliable basis for selecting which branches
to embolize, many patients would have to be treated
before operation for every postoperative treatment that
would be prevented. Packing the aneurysm with thombo-
genic material at the time of operation appears to be more
promising. The group from Nottingham, United
Kingdom, has reported a zero rate of endoleak after selec-
tive application of this technique.21
We take the view that if a collateral connection
between two arterial beds is too small to admit a catheter,
it is probably too small to sustain flow or contribute much
to the pressure in the recipient arterial bed. Conversely, a
large connection would maintain a high pressure environ-
ment within the aneurysm, making dilation likely, and
high flow through the aneurysm, making spontaneous res-
olution unlikely. In this series, the most troublesome type
II endoleaks were fed through the large marginal arcade
between the superior mesenteric and inferior mesenteric
territories. The only instances of aneurysm enlargement
occurred when IMA embolization had to be delayed by
the patients’ other medical problems. Once the IMA was
embolized, the aneurysm ceased to dilate.
Studies on the natural history of type II endoleak have
produced varying conclusions.10,11 However, these differ-
ences are probably attributable to a combination of small
study size, variation in diagnostic (CT) technique, and the
underlying heterogeneity of type II endoleaks. On the
basis of experience in surgically excluded aneurysms,22 it
appears that continuing perfusion, dilation, pulsatility, and
rupture risk (endoleak) is quite rare (4%), even if one
includes the cases in which persistent aneurysm perfusion
was treated at the time of the original operation.
Returning to the endovascular literature, type II
endoleaks are generally associated with less pulsatility of
the aneurysm wall than type I endoleaks.23 On the other
hand, recent transcatheter measurements of aneurysm
pressure at the time of embolization for type II endoleak
show values close to systemic.24 Of course, these readings
could not have been taken if the collateral connection had
not been large enough to admit a catheter, which is cer-
tainly not the case in all instances of endoleak.
Our policy of observation depends not only on the
anticipated behavior of type II endoleak, but also on the
ability to distinguish type II from type I without an
angiogram. This in turn depends on the quality of CT data
acquisition and processing. If the distinction between
these types cannot be made by CT scanning, it may be
necessary to obtain an angiogram to be certain that a type
I endoleak is not present. Having obtained selective
angiograms, we find it hard to argue against attempting
embolization. If the feeding arteries can be catheterized
easily and occluded close to the aneurysm, there is little
risk of inducing ischemia in the lumbar or IMA territory.
We conclude that type I endoleaks represent a techni-
cal failure of endovascular repair that should be corrected
promptly by endovascular means. On the other hand, type
II endoleaks are generally benign enough to warrant a
period of observation. In these cases, immediate
embolization of feeding collateral vessels is often difficult,
futile, and unnecessary. However, these conclusions are
based on a relatively short period of observation in a small
number of cases. We still recommend early angiography
with embolization when the aneurysm is very large, the
CT scan does not exclude the possibility of type I
endoleak, or regular CT-based follow-up is problematic.
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